Benjamin Besse, President-Elect of EORTC and Head of Clinical Research at Gustave Roussy, shared a post on X about a paper he co-authored with colleagues published in Nature Reviews Disease Primers:
“Up to 50% of patients with metastatic cancer develop lung metastases, linked to poor prognosis and impaired quality of life.
Our Nature Reviews Disease Primers article unpacks biology, diagnosis, and treatment strategies.”
Title: Lung metastases
Authors: Lodovica Zullo, Dimitris Filippiadis, Lizza E. L. Hendriks, Daniel Portik, Jonathan D. Spicer, Ignacio I. Wistuba, Benjamin Besse
You can read the Full Article on Nature Reviews Disease Primers.
More posts featuring Benjamin Besse.
